| Ms Phylliss Lamora Flowers, FNP | |
|
5511 Virginia Way, Ste 300, Brentwood, TN 37027-7611 | |
| (615) 994-1000 | |
| (615) 994-0100 |
| Full Name | Ms Phylliss Lamora Flowers |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 5511 Virginia Way, Brentwood, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063666261 | NPI | - | NPPES |
| Entity Name | Cedar Recovery Center Of Middle Tennessee, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801345285 PECOS PAC ID: 0446671440 Enrollment ID: O20200529001321 |
News Archive
Medrobotics Corp., a medical robotics company, announced today that the Company received the CE mark for the Flex System and will initiate a limited commercial launch of the product in select European markets.
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled "Buccal, Polar and Non-polar Spray Containing Zolpidem," which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.
Ligand Pharmaceuticals Incorporated announced today that it has purchased from the Genaera Liquidating Trust certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by AstraZeneca's subsidiary, MedImmune. MEDI-528 is currently in a 320-patient Phase II study for moderate-to-severe asthma.
Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease - Duchenne muscular dystrophy (DMD) - for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Phylliss Lamora Flowers, FNP 5511 Virginia Way, Ste 300, Brentwood, TN 37027-7611 Ph: (615) 994-1000 | Ms Phylliss Lamora Flowers, FNP 5511 Virginia Way, Ste 300, Brentwood, TN 37027-7611 Ph: (615) 994-1000 |
News Archive
Medrobotics Corp., a medical robotics company, announced today that the Company received the CE mark for the Flex System and will initiate a limited commercial launch of the product in select European markets.
Noting that an estimated $2 billion was spent on the U.S. presidential campaigns, Peter Hotez, president of the Sabin Vaccine Institute and founding dean of the National School of Tropical Medicine at the Baylor College of Medicine, writes in the Huffington Post "Healthy Living" blog, "Many of us in the global health community can only look upon that $2 billion figure in awe because of the potential for those dollars to be repurposed to immediately and dramatically improve the lives of the poorest people who suffer from disease."
NovaDel Pharma Inc., today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715, entitled "Buccal, Polar and Non-polar Spray Containing Zolpidem," which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaMist™ Oral Spray spray technology.
Ligand Pharmaceuticals Incorporated announced today that it has purchased from the Genaera Liquidating Trust certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by AstraZeneca's subsidiary, MedImmune. MEDI-528 is currently in a 320-patient Phase II study for moderate-to-severe asthma.
Researchers at Duke University have shown that a single systemic treatment using CRISPR genome editing technology can safely and stably correct a genetic disease - Duchenne muscular dystrophy (DMD) - for more than a year in mice, despite observed immune responses and alternative gene editing outcomes.
› Verified 5 days ago
Jaclyn R Cominotto, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1642 Westgate Cir Ste 202, Brentwood, TN 37027 Phone: 615-941-8550 | |
Ms. Lakesha Monique Goodwin, AGPCNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5511 Virginia Way, Ste 300, Brentwood, TN 37027 Phone: 615-994-1000 Fax: 615-994-0100 | |
Alyssa Cotton, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8 Cadillac Dr, Suite 250, Brentwood, TN 37027 Phone: 615-425-4287 | |
Carol Lehman, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8 Cadillac Dr, Suite 250, Brentwood, TN 37027 Phone: 615-425-4287 | |
Tracy Maurice Abney, DNP, PMHNP, ACNS Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 103 Continental Pl Ste 120, Brentwood, TN 37027 Phone: 615-488-3121 | |
Nicola Ann Farmer, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 111 Westwood Pl Ste 100, Brentwood, TN 37027 Phone: 615-762-3350 | |
Dhrumini Girishkumar Patel, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1805 Williamson Ct, Brentwood, TN 37027 Phone: 615-454-6917 Fax: 888-491-9394 |